Previously Funded Researchers
See researchers who have made a difference in research we have funded in previous years through our nationwide research awards, showcasing the breadth of the work and scientists we have supported.-
Shumin Tan, Ph.D.
Tufts University
How Does Mycobacterium Tuberculosis Adapt to Life in Humans?
-
Shumin Tan, PhD
Tufts University
Gaining Insights into a Regulator that Affects Growth of Mycobacterium tuberculosis
-
Moon-Shong Tang
New York University School of Medicine
Do E-Cigarettes Lead to Lung Cancer?
-
Wei Tao, PhD
Brigham and Women's Hospital, Inc.
Inhalation Delivery of mRNA via Targeted NPs for Lung Cancer Treatment
-
Alison Taylor, PhD
Columbia University
Effect of Changes in Chromosome Number in Lung Squamous Cell Carcinoma
-
Kathryn L. Taylor, PhD
Georgetown University
Testing Methods to Increase Lung Cancer Screening Among Quitline Callers
-
Steven Templeton
Indiana University
Adiponectin-Mediated Inhibition of Detrimental Inflammation in Invasive Aspergillosis
-
Justine Tigno-Aranjuez
University of Central Florida
Negative Regulation of Allergic Asthma by LMAN1, a Novel Receptor for House Dust Mite
-
Trent Tipple, MD
University of Oklahoma, Health Sciences Center
Determing Selenium’s Role in Bronchopulmonary Dysplasia
-
Lara Traeger, PhD
Massachusetts General Hospital
Addressing Needs of Lung Cancer Patients Facing Risk of Recurrence
-
Phuoc Tran, M.D., Ph.D.
Johns Hopkins University
Targeting a Gene Involved in Lung Cancer Drug Resistance
-
Matthew Triplette, MD, MPH, BA
Fred Hutchinson Cancer Research Center
Assisting in Smoking Cessation and Lung Cancer Screening in Indigenous People in SeaTle (ASSIST)
-
MuChun Tsai, MD
Ohio State University Office of Sponsored Programs
MARCH10 Effects on Cilia During Influenza Infection
-
Alexei Tumanov, M.D., Ph.D.
Columbia University
Investigating Origins of Idiopathic Pulmonary Fibrosis Development
-
Argyrios Tzouvelekis, Ph.D.
Yale University
Enzyme Could Play Key Role in Idiopathic Pulmonary Fibrosis
-
Johanna Uthoff
University of Iowa
Lung Cancer Risk Assessment Using Quantitative Imaging
-
Anna Volerman, MD
University of Chicago
Evaluating Asthma Management Policy in Chicago Schools
-
Narendra Wajapeyee, Ph.D.
Yale University
Targeting p53 Gene to Treat Lung Cancer
-
Guanghu Wang, Ph.D.
Georgia Regents University
Fighting Drug Resistance in Lung Cancer
-
Jing Gennie Wang, MD
Ohio State University
Determining Influence of Plant-Based Diet on Asthma and Response to Air Pollution
-
Yanzhuang Wang, PhD
The Regents of the University of Michigan
SARS-CoV-2 Modulates the Golgi Structure to Facilitate Viral Trafficking
-
Jeffrey P. Ward, MD, PhD
Washington University School of Medicine
Personalized Neoantigen Vaccine and Durvalumab in ES-SCLC
-
Noel Warfel, Ph.D.
University of Arizona
Blocking Enzyme PIM Kinase to Treat Non-Small Cell Lung Cancer
-
Hideo Watanabe, M.D., Ph.D.
Icahn School of Medicine at Mount Sinai
Understanding the Complexity and Variability of Lung Tumors
-
Hideo Watanabe, MD, PhD
Icahn School of Medicine at Mount Sinai
Distinguishing Different Subgroups of Lung Cancer to Improve Treatment
-
Pamela Wearsch, Ph.D.
Case Western Reserve University - School of Medicine
Particles in TB Membrane Could be Target for Treatment
-
Nathaniel Weathington, M.D., Ph.D.
University of Pittsburgh
Testing New Drug Therapies for Acute Respiratory Distress Syndrome Using Donor Lungs
-
Kipp Weiskopf, MD, PhD
Whitehead Institute for Biomedical Research
Discovering More Effective Ways to Treat KRAS Mutant Lung Cancer
-
Gary A. Weisman, PhD
The Curators of the University of Missouri
P2Y2 receptor-integrin interactions in Spike- and ACE2-mediated SARS-CoV-2 entry in lung alveolar epithelial cells
-
Daniel Weiss, MD, PhD
The University of Vermont State and Agricultural College
Mechanisms of SARS-CoV-2 induced type 2 alveolar epithelial cell pathogenesis
